These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29863694)

  • 1. [Improvement of the efficacy of treatment of hypertensive encephalohathy by using mexidol].
    Bolotova EV; Lushpay NY; Kovrigina IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(4):61-64. PubMed ID: 29863694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of a cohort single-center randomized study of the modulating effect of the drug Mexidol in the rehabilitation of patients who suffered acute cerebral insufficiency].
    Belkin AA; Belkin VA; Vasilchenko IE; Pinchuk EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(4):108-117. PubMed ID: 38676685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of the sequential use of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia].
    Abramenko YV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):59-64. PubMed ID: 32307432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characteristics of anxiety in patients of older age groups with different types of mild cognitive disorder].
    Sidenkova AP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):45-50. PubMed ID: 29265086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The efficacy and safety of Mexidol Forte 250 as part of long-term sequential therapy in patients with carotid stroke].
    Strelnikova IA; Svetkina AA; Androfagina OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):54-58. PubMed ID: 32307431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The study of the efficacy and safety of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia].
    Kutashov VA; Ulyanova OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(12. Vyp. 2):89-92. PubMed ID: 32207723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and safety of the drug mexidol FORTE 250 as part of sequential therapy in patients with chronic ischemia of the brain].
    Chukanova EI; Chukanova AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9):39-45. PubMed ID: 31626217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Improving the effectiveness of pharmacotherapy in comorbid patients with chronic cerebral ischemia on an outpatient basis].
    Vizilo TL; Arefieva EG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(3):51-55. PubMed ID: 36946397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO)].
    Fedin AI; Zakharov VV; Tanashyan MM; Chukanova EI; Madzhidova EN; Shchepankevich LA; Ostroumova OD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11):7-16. PubMed ID: 34932280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The efficacy and safety study of Mexidol and Mexidol FORTE 250 in patients with chronic cerebral ischemia].
    Shchepankevich LA; Nikolaev YA; Taneeva EV; Pervuninskaya MA; Shchepankevich MS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(10):32-37. PubMed ID: 34874652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The efficacy of antioxidant treatment with mexidol forte in 250 patients with chronic cerebral venous insufficiency].
    Chukanova EI; Chukanova AS; Mamaeva KI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(3):57-63. PubMed ID: 33834719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of mexidol on oxidative stress in cerebral variant of hypertensive crisis].
    Golikov AP; Golikov PP; Davydov BV; Riabinin VA; Luk'ianov MM; Kalinin AN; Klychnikova EV; Promanenkov VK
    Kardiologiia; 2002; 42(3):25-9. PubMed ID: 12494182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Persian Version of the 8-Item Morisky Medication Adherence Scale (MMAS-8) in Iranian Hypertensive Patients.
    Moharamzad Y; Saadat H; Nakhjavan Shahraki B; Rai A; Saadat Z; Aerab-Sheibani H; Naghizadeh MM; Morisky DE
    Glob J Health Sci; 2015 Jan; 7(4):173-83. PubMed ID: 25946926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The results of the study of the efficacy and safety of mexidol in patients with chronic cerebral ischemia].
    Chukanova EI; Chukanova AS; Mamayeva KI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(2):71-74. PubMed ID: 26081329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The assessment of the clinical efficacy, vasoactive and metabolic effects of mexidol in elderly patients with discirculatory encephalopathy].
    Abramenko IuV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(11 Pt 1):35-41. PubMed ID: 22611676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the efficacy and safety of sequential use of the drugs Mexidol and Mexidol FORTE 250 in the treatment of stroke].
    Karpov SM; Morozova MY; Muravyov KA; Vyshlova IA; Kantemirova FS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(3. Vyp. 2):59-62. PubMed ID: 35318844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 8-item Morisky Medication Adherence Scale: validation of a Brazilian-Portuguese version in hypertensive adults.
    de Oliveira-Filho AD; Morisky DE; Neves SJ; Costa FA; de Lyra DP
    Res Social Adm Pharm; 2014; 10(3):554-61. PubMed ID: 24268603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of Mexidol in patients with mild (moderate) cognitive impairment: results of a meta-analysis].
    Zakharov VV; Vakhnina NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(1):82-88. PubMed ID: 38261288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The efficacy of mexidol for transient ischemic attacks in the vertebrobasilar system in elderly patients with chronic cerebral ischemia].
    Abramenko YV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(9. Vyp. 2):42-48. PubMed ID: 30499559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possibilities of improving the effectiveness of therapy in patients with chronic cerebral ischemia against the background of COVID-19].
    Kovalchuk VV; Ershova II; Molodovskaya NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(3. Vyp. 2):60-66. PubMed ID: 33908234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.